Physician profile
Dimitri Greschner
NPI 1831365048
$1,014.35
in general payments reported to CMS, 2019-2025
12 companies · $291 in 2025
The $291 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $53.09 · 2022: $166 · 2023: $191 · 2024: $314 · 2025: $291.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $795.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $794.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $283.75 | 2019-2025 | Sapien 3 Ultra Resilia |
| Abbott Laboratories | $155.81 | 2022-2025 | Navitor, Perclose Prostyle |
| Medtronic, INC. | $94.99 | 2023-2025 | Selectsecure, Corevalve Evolut R, Linq II |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $86.88 | 2024-2025 | Lifevest |
| Cardiva Medical, INC. | $82.05 | 2024 | Savvywire |
| Shockwave Medical, INC | $82.04 | 2022-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Teleflex LLC | $75.28 | 2023-2025 | Guideliner, Langston, Vascband |
| Abiomed | $64.17 | 2023-2024 | Impella |
| Novartis Pharmaceuticals Corporation | $33.00 | 2024 | |
| Cook Medical LLC | $19.25 | 2023 | Lunderquist |
| Terumo Medical Corporation | $18.64 | 2025 | Angio-Seal |
| Astrazeneca Pharmaceuticals Lp | $18.49 | 2023 | Farxiga |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dimitri Greschner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.